Aldagen Announces Texas Heart Institute As First Site In Its Stem Cell Clinical Trial To Treat Critical Limb Ischemia

Source: Aldagen, Inc.
Date: December 15, 2006

Summary:

Aldagen, Inc. announced that the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas will be the first site for its clinical trial using Aldagen’s ALDESORT® product to isolate a unique stem cell population as therapy for critical limb ischemia (CLI) patients.